Atai Life Sciences Total Long-Term Assets 2020-2024 | ATAI

Atai Life Sciences total long-term assets from 2020 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Atai Life Sciences Annual Total Long-Term Assets
(Millions of US $)
2023 $108
2022 $18
2021 $39
2020 $12
2019 $23
Atai Life Sciences Quarterly Total Long-Term Assets
(Millions of US $)
2024-06-30 $98
2024-03-31 $152
2023-12-31 $108
2023-09-30 $92
2023-06-30 $11
2023-03-31 $13
2022-12-31 $18
2022-09-30 $25
2022-06-30 $25
2022-03-31 $35
2021-12-31 $39
2021-09-30 $42
2021-06-30 $48
2021-03-31 $14
2020-12-31 $12
2020-09-30
2020-06-30
2020-03-31
2019-12-31 $23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.265B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00